EFFICACY AND SAFETY OF CRISABOROLE IN PATIENTS ≥3 MONTHS OF AGE WITH MILD-TO-MODERATE ATOPIC DERMATITIS (AD)

被引：0

作者：

Su, John C. ^{[1
]}

Spelman, Lynda J. ^{[2
]}

Eichenfield, Lawrence F. ^{[3
,4
]}

Gold, Linda F. Stein ^{[5
]}

Cha, Amy ^{[6
]}

Graham, Daniela ^{[7
]}

Takiya, Liza ^{[8
]}

Werth, John L. ^{[9
]}

Zang, Chuanbo ^{[10
]}

Vlahos, Bonnie ^{[11
]}

机构：

[1] Univ Melbourne, Murdoch Childrens Res Inst, Melbourne, Vic, Australia

[2] Verac Clin Res, Brisbane, Qld, Australia

[3] Univ Calif San Diego, Rady Childrens Hosp San Diego, Pediat & Adolescent Dermatol, San Diego, CA USA

[4] Univ Calif San Diego, Dept Dermatol & Pediat, San Diego, CA USA

[5] Henry Ford Hlth Syst, Dept Dermatol, Detroit, MI USA

[6] Pfizer Inc, Global Med Affairs Inflammat & Immunol, New York, NY USA

[7] Pfizer Inc, Hlth Econ & Outcomes Res Patient & Hlth Impact In, Collegeville, PA USA

[8] Pfizer Inc, North Amer Med Affairs Inflammat & Immunol, Collegeville, PA USA

[9] Pfizer Inc, Clin Dev & Operat, Collegeville, PA USA

[10] Pfizer Inc, Biostat, Collegeville, PA USA

[11] Pfizer Inc, Global Prod Dev Inflammat & Immunol, Collegeville, PA USA

来源：

ACTA DERMATO-VENEREOLOGICA | 2021年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

PT12

引用

页码：55 / 56

页数：2

共 50 条

[1] Crisaborole in patients ≥3 months of age with mild-to-moderate atopic dermatitis (AD)
Su, J. C.
Spelman, L. J.
Eichenfield, L. F.
Gold, L. F. Stein
Cha, A.
Graham, D.
Takiya, L.
Werth, J. L.
Zang, C.
Vlahos, B.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (07) : S70 - S70
[2] Crisaborole ointment, 2%, in patients 3 months of age and older with mild-to-moderate atopic dermatitis (AD)
Su, J. C.
Spelman, L. J.
Eichenfield, L. F.
Gold, L. F. Stein
Cha, A.
Graham, D.
Takiya, L.
Werth, J. L.
Zang, C.
Vlahos, B.
AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2021, 62 : 123 - 124
[3] Efficacy And Safety Of Crisaborole In Patients Aged 3 Months To 17 Years With Mild-To-Moderate Atopic Dermatitis
Su, John C.
Spelman, Lynda J.
Eichenfield, Lawrence F.
Stein, Linda F.
Cha, Amy
Graham, Daniela
Takiya, Liza
Werth, John L.
Zang, Chuanbo
Vlahos, Bonnie
PEDIATRICS, 2021, 147 (03)
[4] Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities
Spergel, Jonathan M.
Blaiss, Michael S.
Lio, Peter
Kessel, Aharon
Cantrell, Wendy C.
Takiya, Liza
Werth, John L.
O'Connell, Michael A.
Zang, Chuanbo
Cork, Michael J.
ALLERGY AND ASTHMA PROCEEDINGS, 2021, 42 (05) : 425 - 431
[5] Safety Of Crisaborole In Patients Aged 3 To <24 Months With Mild-To-Moderate Atopic Dermatitis
Shepard, Julie S.
Schlessinger, Joel
Gower, Richard G.
Su, John C.
Lynde, Charles
Cha, Amy
Graham, Daniela
Takiya, Liza
Werth, John L.
Zang, Chuanbo
Vlahos, Bonnie
PEDIATRICS, 2021, 147 (03)
[6] Efficacy and safety of crisaborole by body region in infants with mild-to-moderate atopic dermatitis
Schlessinger, Joel
Shepard, Julie S.
Forsha, Douglass W.
Zaenglein, Andrea L.
Werth, John L.
Zang, Chuanbo
Cha, Amy
Takiya, Liza
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB125 - AB125
[7] Efficacy and Safety of Crisaborole by Body Region in Infants with Mild-to-moderate Atopic Dermatitis
Forsha, Douglass W.
Schlessinger, Joel
Shepard, Julie S.
Werth, John L.
Zang, Chuanbo
Cha, Amy
Takiya, Liza
PEDIATRICS, 2022, 149 (01)
[8] Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis with and without comorbid allergies or asthma
Lio, Peter A.
Spergel, Jonathan M.
Cork, Michael J.
Blaiss, Michael S.
Kessel, Aharon
Cantrell, Wendy C.
Werth, John L.
O'Connell, Michael A.
Zang, Chuanbo
Takiya, Liza
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB97 - AB97
[9] Efficacy and Safety of Crisaborole in Patients With Mild-to-Moderate Atopic Dermatitis With Comorbid Allergic Rhinitis or Asthma
Spergel, Jonathan
Blaiss, Michael
Lio, Peter
Kessel, Aharon
Takiya, Liza
Werth, John
O'Connell, Michael
Zang, Chuanbo
Cork, Michael
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB28 - AB28
[10] Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis with and without comorbid allergies or asthma
Lio, P.
Cork, M. J.
Blaiss, M. S.
Kessel, A.
Cantrell, W. C.
Werth, J. L.
O'Connell, M.
Zang, C.
Takiya, L.
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E110 - E110

← 1 2 3 4 5 →